📣FAO EndoHepatology Enthusiasts
Thrilled to invite contributions for Livers Special Edition. If you’re passionate about the intersection of endoscopy & hepatology, we would be delighted to feature your insights & research.
Don’t miss the opportunity to contribute to the field
From the biggest regret in life i.e. delaying Dx of my own daughter’s CD to collective efforts to encourage UK restaurants to achieve Coeliac UK accreditation & reliably provide GF meals.
🙏 UEG President @joostphdrenth
for joining me to support this initiative
#BSGLive2026
Many congratulations @MitraVikramjit & team this well-deserved accolade. A fitting recognition for a great friend, a compassionate and wonderful human being, an outstanding academic, and highly skilled advanced HPB endoscopist. Truly well deserved. #BSGLive2026
Talking AI (CADe & CADx) with the master of quality metrics, Prof Doug Rex, at the #BSGLive2026
🗝️takeaway: CADe is not quite ready for prime time yet! We need better understanding of how to train & validate algorithms, with concerns around missed clinically important lesions
Wish to excel in therapeutic EUS? make sure your diagnostic EUS foundations are rock solid.
This course brings together a truly stellar faculty & is an opportunity not to be missed. I'll be tuning in to learn from the experts @docdhir@DrLakhtakia@Samanta_JayPGI@drsridhars
The Fantastic Five behind the iEUS #Endohepatology Consensus Conference
Thank you for making it happen. Outstanding science, wonderful company, and the unforgettable warmth of Sicilian hospitality. 🇮🇹🍋
Alhamdulillah (ٱلْحَمْدُ لِلَّٰهِ)
From the Foothills of Himalayas to the Annals of Global Medicine. The Revolutionary Discoveries and Scientific Legacy of Dr. Mohammad Sultan Khuroo
The "Big Six" Discoveries: A legacy of Innovation.
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq
@ASCO
OVERALL SURVIVAL DOUBLED!!!!!
In pancreatic cancer. 🤯
That alone is remarkable. But what also stands out is seeing a KRAS-targeted therapy generate an OS curve like this in a disease where meaningful advances have historically been SO difficult! #ASCO26@ASCO
The i-EUS 🇮🇹 #Endohepatology Consensus Conference comes to an end. An inspiring few days of discussion & debate. We hope the forthcoming consensus manuscript will help shape endohepatology practice across Europe & around the world, with one ultimate goal: improving patient care.
Prof Van Der Merwe highlighted a critical message for #EndoHepatology community:
advancing pt care requires alignment in our goals and our pathways with the broader hepatology community #EASLCongress
i-EUS EndoHepatology Consensus Conference 🇮🇹
Marcello Maida outlining the ground rules for the consensus conference
Setting the tone for what promises to be a lively discussion.
i-EUS #EndoHepatology consensus conference 🇮🇹
Starting the i-EUS #Endohepatology Consensus Conference in Sicily 🇮🇹 with a masterclass from Marc Giovannini, MD the Maestro on liver applications of interventional EUS.
An inspiring start to what promises to be a landmark meeting in endohepatology.
MAES EUS/ERCP 2026 final programme is out!
📍 Manchester 15–17 July 2026
Join us for live EUS & ERCP cases, international faculty, hands-on training, expert debates, abstract presentations with awards, and the latest advances in HPB endoscopy